TREM2 deficiency has produced both neurotoxic effects and exacerbated tau pathology in a primary tauopathy model [98, 99] as well as neuroprotection with the prevention of brain atrophy without affecting phosphorylated tau levels [100]. The gene discussed is MAPT; the disease is tauopathy.